severe course of the disease in them," says Professor Cornberg. Hepatitis B can be treated well at an early stage, hepatitis C can even be cured. Professor Dr Michael P. Manns, MHH President and Chairman [...] stage "We have re-evaluated 165 recommendations and adapted them to the current situation," says Professor Dr Markus Cornberg, Deputy Director of the MHH Clinic for Gastroenterology, Hepatology and Endocrinology [...] not only in the 32nd week of pregnancy, as stipulated in the maternity guidelines," emphasises Professor Cornberg. "Early antiviral therapy can lower the mother's viral load and thus prevent chronic infection

of the Emmy-Noether program (phase 2), then as a junior/W2 professor at Charité - Universitätsmedizin Berlin. The scientific work of Professor Schmidt-Ott is funded by the German Research Foundation (DFG) [...] up the W3 professorship in Nephrology as Chief of the Department of Nephrology and Hypertension. Professor Schmidt-Ott's clinical expertise covers the fields of nephrology and hypertensiology, including [...] Federal Ministry of Education and Research, and the Urological Research Foundation. Currently, Professor Schmidt-Ott is a board member in two DFG-funded collaborative projects (Collaborative Research Unit

kidney donated by his mother. "This proves the efficiency of the MHH," emphasizes MHH Vice President Professor Dr. Frank Lammert , responsible for the department of patient care. "At the MHH Transplant Center [...] makes possible interventions that are unique nationwide." Transplant medicine at MHH was founded by Professor Dr. Rudolf Pichlmayr, who first established kidney and then liver transplantation. "Kidneys and [...] and livers now account for two-thirds of the organs transplanted at MHH," says his successor, Professor Dr. Jürgen Klempnauer, director of the MHH-Department for General, Visceral and Transplant Surgery

faecal incontinence. Despite intensified relapse therapy, permanent impairments can occur," explains Professor Dr. Corinna Trebst, head of the study and vice director of the Department of Neurology. Large m [...] insufficient data on NMOSD and MOGAD in this regard. Dr. Hümmert coordinated the study together with Professor Trebst. 212 patients were included in the multicentre study - a very large number for a rare disease [...] study group, a network of more than 60 NMOSD centres in Germany, Austria and Switzerland," says Professor Trebst. MHH Neurology is one of the leading NEMOS centres. Through the network, the study initiators

SERVICE: For further information, please contact Professor Dr Günter Höglinger, hoeglinger.guenter@mh-hannover.de , telephone (0511) 532-2390, and Professor Dr Karin Weißenborn, weissenborn.karin@mh-hannover [...] permanent damage. The nationwide "Day against the Stroke" takes place on 10 May. On this occasion, Professor Dr Günter Höglinger reminds us how important it is to act immediately at the first sign of a stroke [...] the brain must be restored optimally within a maximum of 4.5 hours after the stroke," explains Professor Dr Karin Weißenborn, head of the certified supraregional stroke unit at the MHH Department of Neurology

Secretary +49 511 532 6701 helmsen.alexandra @ mh-hannover.de Profile ABOUT Rainer Blasczyk is Full Professor of Transfusion Medicine and Head of the Institute of Transfusion Medicine and Transplant Engineering [...] After being appointed to his current position he initiated the research on transplant engineering. Professor Blasczyk has a long term research interest in solid organ transplantation and transplantation immunology [...] as well as genetic and transplant engineering approaches to achieve transplantation tolerance. Professor Blasczyk is founder and chairman of the Immunotherapy Foundation. He has been a member of the Advisory

(MHH), in collaboration with specialists from the Neuro-oncology Centre led by Professor Hartmann from Neuropathology and Professor Krauss from Neurosurgery, as well as with partners from the University Medical [...] trait combination of Siglec-16 and polysialic acid, we observed a tumour-inhibiting effect," says Professor Dr Herbert Hildebrandt, project leader in the DFG-funded research group 2953 "Sialic acid as a regulator [...] be detected in more than 80 per cent of the glioblastomas examined," adds Dr Hauke Thiesler from Professor Hildebrandt's research group. "A simple genetic test in combination with other factors could enable

ideal for punctures, for example to take tissue samples or to remove pus accumulations," explains Professor Dr. Frank Wacker, Director of the Institute for Diagnostic and Interventional Radiology. With the [...] punctures are now also easier to perform. The path is determined by the laser beams," explains Professor Wacker. In his institute, the new device is also used for thermal ablations - tumours of the liver [...] we need less time for the interventions and the patients are exposed to less radiation," says Professor Dr. Wacker. In addition, the new device is very suitable for the further training of junior staff

virus-infested cells and tumor cells. This makes NK cells interesting helpers in cancer therapy. Professor Dr. Dr. Axel Schambach, head of the Institute of Experimental Haematology at the Hannover Medical [...] ensure greater targeting accuracy and more extensive destruction of the tumor cells,” explains Professor Schambach. In order to activate the NK cells, they receive an additional genetic code for the chimeric [...] structures that are mainly located on the tumor cell, but not on the patient’s immune cells,” says Professor Schambach. Soften immunosuppression in tumor environment However, the CAR-NK cells have a further

multi-centre study with 150 participants, an international research team led by Professor Dr. Heiner Wedemeyer and Professor Dr. Markus Cornberg from the Department of Gastroenterology, Hepatology, Infectiology [...] show how long the patients will have to be treated in the end. The researchers led by Professor Wedemeyer and Professor Cornberg are also investigating this in the EU-funded research project D-Solve. What [...] "We tested the antiviral activity on 150 patients who were infected with both HBV and HDV," says Professor Cornberg. "Of these, just under half had already developed liver cirrhosis, i.e. scarred liver tissue